In the present study, we explored the relationship between STMN1 in liver cancer function enrichment, immune infiltration, DNA methylation, and m6A, providing new evidence that STMN1 is a prognostic marker that can be exploited as a therapy target for HCC. Here, STMN1 is linked to hepatocellular carcinoma.